Why the study?
Does proactive care and active discussion of quality of death improve end-of-life experiences for patients with congestive heart failure and implantable cardioverter defibrillators?
Does proactive care and active discussion of quality of death improve end-of-life experiences for patients with congestive heart failure and implantable cardioverter defibrillators?
Answers are grounded in this paper and cite their sources.
Proactive discussion regarding quality of death and potential device deactivation is essential in heart failure patients with ICDs to prevent unnecessary interventions at the end of life.
OBJECTIVES: The purpose of this paper is to discuss quality of death (QOD) among patients with congestive heart failure (CHF) and implantable cardioverter defibrillators. We outline recommendations that enhance QOD from the device patient and specialty cardiology perspectives. BACKGROUND: Contemporary treatment of CHF patients routinely includes both pharmacologic therapy and the use of cardiac devices. The implantable cardioverter defibrillator prevents premature death in heart failure patients, though not death itself. CONCLUSIONS: Active discussion and consideration of patient's QOD is indicated in implantable cardioverter defibrillator patients to prevent unnecessary treatment and to increase control over perceived quality of life by patients and family.
No takes yet. Share an insight, caveat, or question.
Sears et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: